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The pathogenic neisseriae can use free heme and hemoglobin as an essential source of iron (Fe) for growth
in vitro, but it is unknown whether they can utilize heme bound to human hemopexin or to human serum
albumin, or hemoglobin bound to haptoglobin. We found that neither Neisseria meningitidis nor Neisseria
gonorrhoeae used bound heme, but bound hemoglobin was used as an Fe source by two meningococcal strains
and one gonococcal strain. A second gonococcal strain, previously shown to use free hemoglobin poorly or not
at all, also did not grow with hemoglobin-haptoglobin complex as an Fe source. These observations suggest that
hemoglobin might act as an Fe source in vivo for many pathogenic neisseriae even when in complexed (bound)
form, but heme probably would not support growth in vivo if bound to serum carrier proteins.
A variety of studies indicate that the ability to acquire iron
(Fe) from an infected host is crucial to the pathogenesis of
many bacterial infections, including those caused by Neis-
seria meningitidis and Neisseria gonorrhoeae (32). For
instance, Holbein et al. (14, 16) demonstrated that mice
injected with Fe-dextran developed a fatal infection when
subsequently injected with live meningococci. Mice not
injected with Fe-dextran sustained only a transient bacte-
remia and were not killed (14). It has been suggested that the
Fe-binding proteins lactoferrin and transferrin (TF) are the
principal Fe sources used in vivo by these organisms (4, 32).
Lactoferrin is probably the major Fe source found on human
mucosal surfaces (21), where both pathogens initiate infec-
tion (21, 22). In invasive disease (bacteremia, meningitis),
the serum protein TF is probably the most important Fe
source for these organisms (22). Supporting this contention,
Holbein (15) has shown that injection of Fe-TF into mice (at
Fe doses far below that required to demonstrate Fe-dextran-
enhanced mortality) effectively supported lethal meningo-
coccal infection. All tested meningococci and gonococci can
use TF as an Fe source (1, 2, 22), whereas all meningococcal
and many gonococcal strains can use lactoferrin as an Fe
source (21).
Yancey and Finkelstein (35) and Mickelsen and Sparling
(22) showed that all meningococci and gonococci tested
could use free heme as a source of Fe. Mickelsen and
Sparling (22) also showed that 20 of 21 meningococcal strains
and 18 of 29 gonococcal strains were capable of using
hemoglobin (Hb) for growth. Brodeur et al. (3) showed that
Hb would enhance meningococcal lethality in mice, similar
to Holbein's observations (15) with Fe-TF. This suggested
that Hb may act as an Fe source in vivo, at least in
experimentally infected mice. However, the majority of Hb
liberated by hemolysis is rapidly bound in plasma by
haptoglobin (Hp) (25); alternatively, Hb may dissociate,
liberating free heme, which is avidly bound by hemopexin
(Hx) or, less tightly, by serum albumin (SA) (25). Eaton et al.
(9) showed that Hp blocked the ability of Hb to donate Fe to
and support the virulence of an invasive Escherichia coli
strain. This suggests that Hp sequesters Hb in a form
unavailable for microbial growth, in addition to facilitating
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the clearance of Hb from the bloodstream (25). Hx and SA
may similarly inhibit microbial growth with heme as an iron
source. We have determined whether meningococci and
gonococci will grow with heme and Hb bound to these serum
proteins, to assess the potential importance of heme and Hb
as in vivo Fe sources.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacteria used
in this study were N. meningitidis strains FAM20 (serogroup
C, serotype 2a) and FAM2 (nonencapsulated, serotype 2a)
and N. gonorrhoeae strains FA19 and F62. These organisms
were routinely cultivated at 37°C in a 5% CO2 atmosphere on
GCB agar (Difco) containing Kellogg's supplements I and II
(19). To examine growth kinetics with various Fe sources,
we used the defined medium of Morse and Bartenstein (24)
with the following modifications (S. E. H. West, Ph.D.
dissertation, University of North Carolina, Chapel Hill,
1986): the phosphate content was reduced to 4 mM, buffer
was added to 21 mM, and ferric nitrate was omitted. This
defined medium was Fe depleted by treatment with Chelex-
100 (Bio-Rad) in batch method; 50 g of Chelex-100 (washed
with 2 liters of deionized distilled H20) was added to 500 ml
of 4x defined medium and stirred for 1.5 h at room temper-
ature, yielding CDM (Chelex-treated, defined medium). The
medium was then filter sterilized. CDM agar plates were
prepared by the addition of sterile molten agarose to 1% final
concentration. Desferal (DF), a potent Fe chelator which
neither meningococci nor gonococci can use for growth (5,
22), was added to bind any free Fe released from heme,
which is unstable in aqueous solution (28). For growth
curves, meningococci were grown overnight (about 18 h) on
CDM agar plates and then suspended in CDM to approxi-
mately 15 Klett units, measured using a Klett-Summerson
colorimeter with a green filter. This culture was incubated
with shaking at 37°C and 5% CO2 until the cells reached
mid-log growth (70 to 80 Klett units); these cultures were
then diluted into fresh CDM plus DF, and individual cultures
were supplemented with various Fe sources as described
below. Gonococci were treated similarly except that over-
night growth was on a CDM plate containing 5 ,uM
Fe(NO3)3; prior experience showed that without small
amounts of Fe supplement for overnight growth, gonococci
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grew poorly or not at all when subsequently suspended in
CDM. Presumably this effect was due to the exhaustion of
internal Fe pools.
Fe sources. Ferric nitrate was used at 100 ,uM final
concentration. Heme and human HbA were obtained from
Sigma Chemical Co. and were prepared fresh daily. Heme
was dissolved at 10 mg/ml in 0.1 M NaOH, diluted with an
equal volume of ethylene glycol, and then diluted 1:5 with
0.1 M Tris-borate buffer (pH 8.35) (31). After thorough
mixing, heme was filter sterilized before use. Hb was dis-
solved in 10 mM HEPES (N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid) (pH 7.4). Complexes of heme with Hx
or SA were prepared by mixing heme with protein to 50%
heme-binding capacity; this combination was incubated with
gentle mixing at room temperature for 30 min before use.
Hb-Hp complexes were prepared similarly. Saturation levels
were calculated using a 1:1 stoichiometry of binding of heme
to Hx and Hb to Hp; heme binding levels to SA were
calculated assuming a 1:1 binding of heme to the primary
heme-binding site on SA. For growth curves, heme was
added to CDM as the free porphyrin or bound to protein at
a final concentration of 2 or 5 ,uM Fe. Hb was added at a final
concentration of 4 ,uAM Fe, either free or complexed with Hp.
Electrophoresis. Immunoelectrophoresis was performed
essentially as described by Grabar and Williams (11), using a
1% agarose gel prepared in 50 mM sodium barbital buffer
(pH 8.2). Electrophoresis was performed at 75 V (constant
voltage) for 50 min, after which the proteins were reacted
with specific antisera for 48 h at 4°C in a moist chamber. The
gel was soaked in several changes of phosphate-buffered
saline (6.4 mM Na2HPO4- 7H20, 0.882 mM KH2PO4, 137
mM NaCl, 2.68 mM KCl) for about 4 h. The gel was then
stained with Coomassie brilliant blue R-250 (27) and
destained. Antisera against various proteins were obtained
from Sigma Chemical Co., except anti-human Hx, which
was from Atlantic Antibodies, Inc.
Sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (SDS-PAGE) was performed using the discontinuous
buffer system of Laemmli (20), as described previously (33).
A nondenaturing PAGE was used to analyze complexes of
Hb and Hp. To do this, SDS was eliminated from all
components of the SDS-PAGE protocol; additionally, sam-
ples were not heated by boiling before electrophoresis. Hb
and Hb-Hp complexes were either visualized by Coomassie
stain or stained for peroxidase activity by using the benzi-
dine stain described by Moore et al. (23).
Serum proteins. Human SA was obtained from Sigma
Chemical Co.; human Hp was obtained either from Sigma or
from Chemicon International, Inc. (El Segundo, Calif.) and
consisted of a mixture of 1-1, 2-1, and 2-2 electrophoretic
variants (17). These were >95% pure as obtained from the
supplier and were found to contain no detectable contami-
nants as judged by SDS-PAGE and immunoelectrophoresis.
Human Hx was purified in a two-step affinity chromatog-
raphy procedure. Outdated, citrated human plasma was
obtained from the North Carolina Memorial Hospital Blood
Bank, heated at 56°C for 30 min to inactivate potential viral
contaminants, and adjusted to 0.5 M NaCl and 0.01%
thimerosal. The plasma was then passed over a heme-
agarose affinity column (30) at a flow rate of 22 ml/h; the
column was subsequently washed with 10 mM sodium
phosphate buffer (pH 7.5) plus 0.5 M NaCl and 0.01%
thimerosal until no UV absorbance (measured at 280 nm)
remained in the eluate. Protein bound to the column was
eluted as a single UV-absorbing peak with freshly deionized








FIG. 1. 10% SDS-PAGE of affinity-purified human Hx. Migra-
tion of molecular mass standards (kdal, kilodaltons) is shown on the
right. Lane 1 contains 20 p.g of protein eluted from the heme-agarose
affinity column; lane 2 contains 20 F±g of Hx eluted from the wheat
germ lectin-Sepharose affinity column. Arrow indicates the position
of the major low-molecular-weight contaminant.
least two changes (4 liters each) of 10 mM HEPES (pH 7.4);
this material was concentrated by ultrafiltration in an
Amicon stirred cell (YM30 membrane) and lyophilized. The
partially pure Hx preparation was dissolved in PNA buffer
(50 mM sodium phosphate [pH 7.0], 0.2 M NaCl, 0.02%
NaN3) and loaded onto a 20-ml wheat germ lectin-Sepharose
CL6B column, as described by Vretblad and Hjorth (31).
After extensive washing with PNA buffer (monitored by UV
absorbance), Hx was eluted from the wheat germ lectin-
Sepharose column by using 20 ml of 100-mg/ml N-
acetylglucosamine in PNA buffer. The eluted protein was
dialyzed, concentrated, and lyophilized as before.
RESULTS
Purification of Hx. Heme-agarose affinity chromatography
yielded an Hx preparation that was routinely 50 to 70% pure,
as judged by SDS-PAGE (Fig. 1); the major contaminant was
a low-molecular-weight protein with an Mr of ca. 24,000. As
we did not identify this contaminant, it is not clear whether
this protein binds to heme-agarose via the heme moiety or by
nonspecific adsorption to the affinity matrix. Some partially
pure Hx preparations also contained small amounts of SA,
which does bind heme; SA was detected by immuno-
electrophoresis (data not shown), since it migrates closely to
Hx on SDS-PAGE. Hx was further purified using wheat
germ lectin-Sepharose affinity chromatography (31). After
this step, Hx was >95% pure by SDS-PAGE (Fig. 1) and
contained no SA, as determined by immunoelectrophoresis
(data not shown). This two-step affinity protocol was faster
and less labor-intensive than the procedure described by
Vretblad and Hjorth (31), which employed polyethylene
glycol precipitation and chromatography on DEAE-
Sepharose CL6B before wheat germ lectin-Sepharose chro-
matography.
Effect of Hx on heme-supported growth. Meningococcal
strain FAM20 grew as rapidly with heme as with excess Fe
(Fig. 2), although growth rarely reached the same final extent
with heme as with Fe(NO3)3 as the Fe source. We commonly
observed a lag period of 1 to 2 h before strain FAM20 began
to grow with heme; this may possibly reflect a period of
metabolic adjustment required before meningococci will
grow with this Fe source, although we have no data to
support this. Heme-Hx complexes did not support FAM20
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FIG. 2. Inability of N. meningitidis FAM20 to grow with heme-
Hx complexes. Log-phase meningococci were diluted into CDM
plus 10 p.M DF (0) or the samne medium supplemented with 100 ,uM
Fe(NO3)3 (0), 2 p.M heme (A), 4 p.M apo-Hx (N), 4 ,uM apo-Hx plus
100 ,uM Fe(NO3)3 (0), or 4 ,uM heme-Hx at 50% saturated heme-
binding capacity (A).
growth better than apo-Hx (Fig. 2). N. meningitidis FAM2
and both strains of N. gonorrhoeae (F62 and FA19) were
also capable of rapid and extensive growth with heme, but
growth was inhibited by binding heme to Hx (data not
shown). Inhibition of heme-dependent growth by Hx was not
due to inhibitory activity unrelated to heme-binding, since
apo-Hx did not inhibit growth in the presence of 100 ,uM
Fe(NO3)3 (Fig. 2). Supplementing CDM with Hx at 200%
saturated heme-binding capacity, which added equivalent
molar amounts of free heme and hemne-Hx complex, also




FIG. 3. Inability of N. meningitidis FAM20 to grow with heme-
SA complexes. Log-phase meningococci were diluted into CDM
plus 10 p.M DF (0) or the same medium supplemented with 100 p.M
Fe(NO3)3 (0), 2 p.M heme (A), 4 p.M SA (N), 4 p.M SA plus 100 p.M
Fe(NO3)3 (O), or 4 p.M heme-SA at 50% saturated heme-binding
capacity (A).
TIME (hours)
FIG. 4. Growth of N. meningitidis FAM20 with Hb-Hp com-
plexes. Log-phase meningococci were diluted into CDM plus 10 ,uM
DF (0) or the same medium containing 100 FM Fe(NO3)3 (0), 1 ,uM
Hb (A), 2 ,M Hp (M), or 2 p.M Hp at 50% saturated Hb-binding
capacity (A).
strains was capable of removing Fe from heme-hx com-
plexes.
Effect of SA on heme-supported growth. Strain FAM20 also
was unable to use hetne when it was bound to SA (Fig. 3);
similar results were observed with strains FAM2, F62, and
FA19. This result was not due to direct inhibition of growth
by SA, since SA added to CDM plus 100 ,uM Fe(NO3)3 had
no inhibitory effect on either the meningococcus (Fig. 3) or
the gonococcus (data not shown).
Effect of Hp on Hb-dependent gkrowth. Both meningococci
and gonococci grew more slowly and to a lower final extent
with Hb than with Fe(NO3)3 (Fig. 4, 5, and 6). Meningococ-
cat strain FAM2O grew better with Hb-Hp complexes than
with free Hb (Fig. 4). Strain FAM2 grew as well with Hb-Hp
complexes as with Hb alone, but did not exhibit ehhanced
growth with Hb bound to Hp (data not shown).
The two gonococcal strains differed in growth response to
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FIG. 5. Growth of N. gonorrhoeae F62 with Hb-Hp complexes.
Log-phase gonococci were diluted into CDM plus 10 p.M DF (0) or
the same medium containing 100 ,uM Fe(NO3)3 (0), 1 ,uM Hb (A), 2
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FIG. 6. Inabilit' of N. gonorrhoeae FA19 to grow with Hb-Hp
complexes. Log-phase gonococci were diluted into CDM plus 10
p.M DF (0) or the same medium containing 100 ,uM Fe(NO3)3 (0),
1 ,uM Hb (A), 2 ,uM Hp (N), or 2 ,uM Hp at 50% saturated
Hb-binding capacity (A).
both Hb and Hb-Hp. Strain F62 (Fig. 5) grew well with both
Hb and Hb/Hp, although there often was a short lag before
growth with Hb commenced. Strain FA19, however, did not
grow appreciably with Hb (Fig. 6), which was previously
noted by Mickelsen and Sparling (22); furthermore, binding
of Hb to Hp did not affect the inability of FA19 to grow with
Hb.
To demonstrate that the Hp preparations were function-
ally capable of binding Hb, we compared apo-Hp, free Hb,
and mixtures of the two by nondenaturing PAGE. Addition
of Hb to Hp resulted in a retardation of the electrophoretic
mobility (Fig. 7A) of both Hb and Hp, consistent with
Hb-Hp complex formation (17). These complexes also con-
tained peroxidase activity (17) not present in apo-Hp (Fig.
7B), due to the heme moiety of Hb (17). However, the Hb
preparation contained a low-molecular-weight contaminant
which had no peroxidase activity (arrow, Fig. 7). Since this
unidentified material might represent free globin, this sug-
gested that free heme might have been liberated by Hb
dissociation and was actually responsible for Hb-Hp-sup-
ported growth. As the Hb-Hp complex is extremely stable,
with a dissociation constant estimated at 2 x i0-7 ,uM (6),
this seemed unlikely, unless Hb dissociation occurred before
the preparation of the Hb-Hp complexes. To check this, we
grew strain FAM 20 with Hb-Hp complexes and excess SA
to bind any free heme in the medium, as we had demon-
strated (above) that SA would block growth with heme.
Growth of FAM20 with Hb-Hp complexes was identical in
the presence and absence of SA (data not shown). We
concluded that Hb was bound to Hp under these conditions
and that these complexes could be used for growth by both
meningococci and gonococci.
DISCUSSION
Of the complexed Fe sources tested, only Hb-Hp com-
plexes could be used by meningococci and gonococci for
growth; neither heme-Hx nor heme-SA yielded essential Fe
to these organisms. These results may partly reflect the
relative exposure of heme on these various complexes. The
primary heme-binding pocket on SA is deeper within the
protein than the fatty acid-binding sites (30), which also can
bind heme with a lower affinity (26). Conversely, binding of
Hb to Hp increases the exposure of heme groups (12),
resulting in enhanced peroxidase activity (18) of the heme
moiety. Since the pathogenic neisseriae use non-sider-
ophore-mediated mechanisms (1, 2, 33) for Fe uptake, it
might not be surprising that the ability to obtain heme-bound
Fe would be related to the exposure of the porphyrin ring.
Our data are similar to those of Stull (29), who found that
Haemophilus influenzae was able to acquire heme from
Hb-Hp complexes. Stull also observed that heme bound to
Hx could be used by H. influenzae, suggesting that this
organism is much more efficient at obtaining heme in vivo
than the pathogenic neisseriae. Vibrio vulnificus has been
shown to grow with Hb-Hp complexes (13), as has non-O1
Vibrio cholerae (Z. Zakaria-Meehan, L. M. Simpson, and
J. D. Oliver, Abstr. Annu. Meet. Am. Soc. Microbiol. 1986,
B239, p. 64), Staphylococcus aureus (10), and Streptococcus
pyogenes (10). In contrast, E. coli (9) growth with Hb is
inhibited by Hp, which also blocks the ability of Hb to
support E. coli infection in rats (9).
The significance of these observations with respect to
clinical disease caused by N. meningitidis and N. gonor-
rhoeae is unclear. Brodeur et al. (3) have recently demon-
strated that Hb can act synergistically with mucin to enhance
meningococcal infection in mice. Mucin pretreatment of
mice resulted in a 50% lethal dose of 5 x 105 CFU, whereas
Hb pretreatment resulted in a 50% lethal dose of 106 CFU;
109 CFU of meningococci was not fatal for mice without
these pretreatments. In contrast, the 50% lethal dose of
meningococci injected into mice treated with both mucin and
Hb was 10 CFU, suggesting that Hb might be used by
meningococci for growth in vivo, although probably not as
efficiently as Fe-TF.
It is also not clear whether Hb would be available to these















FIG. 7. Nondenaturing PAGE of Hb-Hp complexes. (A) 10%
polyacrylamide gel stained for protein with Coomassie brilliant blue;
(B) identical gel stained with benzidine for peroxidase activity. Hp
(15 ,ug), as apo-protein or as 50%- or 200%-saturated protein, was
used in this experiment. As the Hp consisted of a mixture of 1-1, 2-1,
and 2-2 variants (7), it appeared as multiple discrete high-molecular-
weight bands in this nondenaturing PAGE. A 10-,ug sample of Hb
was electrophoresed in the right-hand lane of each gel (identified by
asterisks), which stains faintly with benzidine (B). Arrows show the
low-molecular-weight contaminant in the Hb preparation (A), which
had no demonstrable peroxidase activity (B).
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meningococcemia is often accompanied by disseminated
intravascular coagulation (8), which may release Hb into the
bloodstream by mechanical shearing of erythrocytes (34).
Both disseminated gonococcal infection and pelvic inflam-
matory disease are often associated temporally with menses
(34), but whether Hb is available under this circumstance is
uncertain. However, Hb may yield Fe in vivo to those
strains of N. meningitidis and N. gonorrhoeae capable of
using this Fe source. Our data suggest that heme, on the
other hand, will only provide essential Fe to the pathogenic
neisseriae if it is not bound to the serum carrier proteins Hx
and SA.
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